CD105 (Endoglin) Expression as a Prognostic Marker in Aggressive Papillary Thyroid Carcinoma
This study supports the potential use of CD105 expression and its quantitative indicator, the CD105 MVD score, as biomarkers for distinguishing benign thyroid nodules from malignant ones and for evaluating the prognosis of PTC.
Authors
- Tuğba Günler (ORCID: https://orcid.org/0000-0001-6319-7304)
- İlker Çordan (ORCID: https://orcid.org/0000-0002-5225-4905)
Institutions
- Konya Food and Agriculture University (TR)
- Konya Eğitim ve Araştırma Hastanesi (TR)
- Sağlık Bilimleri Üniversitesi (TR)
Publication Details
- Journal
- Clinical Endocrinology
- Published
- 2025-06-08
- DOI
- https://doi.org/10.1111/cen.15290
- Citations
- 3
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.88